Biosynthesis of rhamnolipid by a Marinobacter species expands the paradigm of biosurfactant synthesis to a new genus of the marine microflora by Tripathi, Lakshmi et al.
Tripathi et al. Microb Cell Fact          (2019) 18:164  
https://doi.org/10.1186/s12934-019-1216-8
RESEARCH
Biosynthesis of rhamnolipid 
by a Marinobacter species expands 
the paradigm of biosurfactant synthesis 
to a new genus of the marine microflora
Lakshmi Tripathi1* , Matthew S. Twigg1, Aikaterini Zompra2, Karina Salek3, Victor U. Irorere1, Tony Gutierrez3, 
Georgios A. Spyroulias2, Roger Marchant1 and Ibrahim M. Banat1
Abstract 
Background: In comparison to synthetically derived surfactants, biosurfactants produced from microbial culture 
are generally regarded by industry as being more sustainable and possess lower toxicity. One major class of biosur-
factants are rhamnolipids primarily produced by Pseudomonas aeruginosa. Due to its pathogenicity rhamnolipid 
synthesis by this species is viewed as being commercially nonviable, as such there is a significant focus to identify 
alternative producers of rhamnolipids.
Results: To achieve this, we phenotypically screened marine bacteria for biosurfactant production resulting in the 
identification of rhamnolipid biosynthesis in a species belonging to the Marinobacter genus. Preliminary screening 
showed the strain to reduce surface tension of cell-free supernatant to 31.0 mN m−1. A full-factorial design was car-
ried out to assess the effects of pH and sea salt concentration for optimising biosurfactant production. When cultured 
in optimised media Marinobacter sp. MCTG107b produced 740 ± 28.3 mg L−1 of biosurfactant after 96 h of growth. 
Characterisation of this biosurfactant using both HPLC–MS and tandem MS showed it to be a mixture of different 
rhamnolipids, with di-rhamnolipid, Rha-Rha-C10-C10 being the most predominant congener. The strain exhibited no 
pathogenicity when tested using the Galleria mellonella infection model.
Conclusions: This study expands the paradigm of rhamnolipid biosynthesis to a new genus of bacterium from the 
marine environment. Rhamnolipids produced from Marinobacter have prospects for industrial application due to their 
potential to be synthesised from cheap, renewable feed stocks and significantly reduced pathogenicity compared to 
P. aeruginosa strains.
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Background
Surfactant compounds possess both hydrophobic and 
hydrophilic moieties: they can modulate surface and 
interfacial tensions and are therefore widely utilised in 
a variety of different industries. Though many of these 
surfactant compounds are derived synthetically from 
petrochemical sources, numerous microorganisms have 
been shown to synthesise surfactant compounds. Sur-
factant compounds produced from a biological source 
are termed biosurfactants and are generally viewed as 
being more sustainable and less toxic than their syntheti-
cally derived alternatives [1]. Marine microorganisms 
have been shown to be able to produce biosurfactants 
under extreme environments, caused by changes in 
salinity, increased UV exposure, limited nutrients, fluc-
tuations in temperatures and pH [2–4]. Many marine 
bacterial species, commonly from oil-contaminated 
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waters, have been reported to produce biosurfactants, 
and include members belonging to the genera Alcanivo-
rax, Alteromonas, Pseudoalteromonas and Halomonas 
[5–7]. The biosurfactants they produce have the ability to 
solubilise hydrocarbons from the surrounding environ-
ment, which enhances the growth of indigenous bacteria 
capable of degrading aliphatic and polycyclic aromatic 
hydrocarbons (PAHs) [8]. These species therefore have 
tremendous industrial potential especially for application 
in microbial enhanced oil recovery (MEOR) and biore-
mediation purposes [7, 9, 10]. Furthermore, biosurfactant 
produced by psychrophilic marine bacteria are poten-
tially exploitable in industrial processes for the prepa-
ration of biological detergents that are active at lower 
temperatures [11].
Particularly in the oligotrophic conditions of open 
ocean environments, marine bacteria have evolved to 
compete for the limited resources available to them. With 
respect to biosurfactants, they may be produced as sec-
ondary metabolites as, for example, to access hydropho-
bic growth substrates or to directly attack rival bacterial 
species competing for limited growth and energy sources 
[12]. In the latter case, biosurfactant compounds could 
be considered applicable for combatting pathogenic anti-
biotic-resistant microorganisms [13, 14]. Biosurfactants 
have also been shown to play an important role in biofilm 
development, the maintenance of biofilm structure and 
in substrate adhesion [15]. Abrogating the bacterium’s 
ability to produce a biosurfactant could therefore disrupt 
biofilm growth with a multitude of potential applications 
including reducing infection risk to patients receiving 
implantable medical devices such as catheters [16, 17].
Biosurfactant compounds possess a wide array of 
molecular structures and are often classified based on 
their structure. One of the best studied groups of bio-
surfactants are the glycolipids, specifically rhamnolip-
ids [10]. Rhamnolipids are composed of one or two 
rhamnose units linked in a 1,2-glycosidic linkage to two 
β-hydroxy fatty acids (β-OH-FA or 3-OH-FA) ranging 
between 8 and 18 carbons in length. The most studied 
rhamnolipids are those produced by the Gram negative, 
opportunistic pathogen Pseudomonas aeruginosa [18]. 
Rhamnolipids have a broad range of potential appli-
cations in various industries, including for MEOR in 
the petroleum industry, as emulsifiers in the food and 
cosmetic industries, and as anti-microbial/therapeuti-
cally-active agents in the pharmaceutical industry [19]. 
Despite their versatile potential industrial applications, 
the exploitation of rhamnolipids has been limited due to 
the pathogenic nature of P. aeruginosa. To overcome this 
there has been an increased interest in the discovery of 
non-pathogenic rhamnolipid producers. Recent reports 
have shown rhamnolipid production by non-pathogenic 
species of Pseudomonas. For example, a non-patho-
genic rhamnolipid-producing marine Pseudomonas sp. 
MCTG214(3b1) was shown to produce both mono and 
di-rhamnolipids [20]. An arctic marine bacterium identi-
fied as Pseudomonas fluorescence species was reported to 
synthesise five mono-rhamnolipid congeners [21]. Out-
side of the Pseudomonas genus, rhamnolipids have been 
shown to be synthesised by a number of non-pathogenic 
species of the genus Burkholderia [22, 23]. Discovery and 
isolation of novel non-pathogenic rhamnolipid produc-
ers is an attractive route to compete with the synthetic 
surfactants and meet future global biosurfactant require-
ments. Global estimates of microbial cell abundances in 
seawater range from  104 to  107  cells/mL, with an esti-
mated average taxonomic diversity of 1000 species/mL 
[24]. Collectively, this offers a significant opportunity to 
discover novel biosurfactant producers, including that 
produce rhamnolipids, and that are non-pathogenic [25]. 
Importantly for commercial exploitation, it is essential 
that the economics underlying the production of the bio-
surfactants is viable and able to compete with chemically-
derived surfactants in the global market. This needs to be 
achieved by reducing manufacturing costs and enhancing 
fermentation yields. There are numerous factors for opti-
mising the process of biosurfactant production, including 
optimising the composition of the culture medium, pH, 
dissolved oxygen levels during growth, culture agitation 
and incubation temperature. Statistical design of experi-
ments (DoE) methods, such as full factorial design (FFD), 
have been shown to be an efficient and useful method to 
optimise biosurfactant production using a reduced num-
ber of experiments [26–28].
In this study, we investigated biosurfactant production 
in five bacterial strains isolated from coastal and offshore 
sites in the USA, Scotland and Norway, and all phyloge-
netically identified to belong to the genus Marinobac-
ter. One of these strains, Marinobacter sp. MCTG107b, 
possessed phenotypic traits indicative of biosurfactant 
synthesis. The bioprocess factors for biosurfactant pro-
duction in this strain were optimised for maximum pro-
duction yield in shake-flask culture using FFD. Using high 
performance liquid chromatography–mass spectrometry 
(HPLC–MS) and tandem-MS, the chemical structure of 
the biosurfactants produced by this strain were analysed 
and confirmed to be rhamnolipids. This study reports the 
first description of rhamnolipid production by a Mar-
inobacter and, importantly also, extends the paradigm of 
rhamnolipid production to a new bacterial genus which 
is recognised as ubiquitous in the marine environment 
and commonly associated with oil spills.
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Materials and methods
Strains and culture conditions
The marine bacteria used in this study were isolated 
from surface seawater samples collected from offshore 
location in the USA, UK and Norway (Table  1). The 
method of isolation has been previously described by 
Twigg et  al. [20]. Following isolation, these strains were 
routinely cultured at 30 °C in ZM/1 medium which con-
sists of 30 g L−1 sea salts (Sigma-Aldrich), 5 g L−1 Bacto 
Peptone (BD Biosciences), 1  g  L−1 yeast extract (Sigma-
Aldrich) and supplemented with trace elements and vita-
mins after autoclaving [29]. P. aeruginosa strain PAO1 
was purchased from the ATCC (ATCC 15692) and was 
cultured at 37 °C in Nutrient Broth (Oxoid). Solid media 
plates used in this study were composed of appropri-
ate culture media supplemented with 1.5% (w/v) agar 
(Sigma-Aldrich).
Phylogenetic identification
Genomic DNA (gDNA) was extracted from approx. 
1 × 108 bacterial cells via a DNeasy Blood and Tissue Kit 
(Qiagen) used as per the manufactures instructions for 
Gram-negative bacteria. Extracted gDNA was quanti-
fied and assessed for purity by measuring absorbance at 
260 nm and 280 nm using a Nanodrop 2000 spectropho-
tometer (Thermo Fischer). The 16S rRNA gene was then 
amplified using the Polymerase Chain Reaction (PCR) 
with the universal primers 9bfm and 1512uR. PCR reac-
tions contained 50 ng of gDNA, 1.5 mM  MgCl2, 1× PCR 
buffer (Thermo Fischer), 0.2 mM dNTP mix (Thermo Fis-
cher), 0.5 mM of each primer (Thermo Fischer), and 2 U 
of Taq DNA polymerase (Thermo Fischer). The PCR reac-
tion was as follows: one cycle initial denaturation at 94 °C 
for 3  min; 30 cycles of denaturation at 94  °C for 45  s; 
annealing step at 52  °C for 30 s; extension step at 72  °C 
for 90 s; and one cycle final extension at 72 °C for 5 min. 
Following amplification, PCR products were separated 
on a 1% (w/v) agarose gel made with TBE buffer (Thermo 
Fischer), and amplicons of approx. 1.5  kb were subse-
quently purified from the gel using a Wizard SV Gel and 
PCR Clean Up System (Promega). Amplified 16S rDNA 
was quantified and assessed for purity as above. The puri-
fied 16S rDNA was sequenced using the Sanger method 
by Eurofins Genomics (Cologne, Germany) with prim-
ers 9bfm, 536F, 907R and 1512uR [30, 31]. The resultant 
DNA sequences were compared to the NCBI nucleotide 
database using BLASTn.
Phenotypic screening for biosurfactant production
The five marine bacterial strains were screened for their 
ability to reduce surface tension and to emulsify oil in 
water. Bacterial cultures were centrifuged at 13,000×g for 
15 min and the supernatant fractions (in triplicate) used 
to perform surface tension measurements at room tem-
perature (21 °C) according to the Du Noüy ring method 
using a K10ST A KRÜSS KIOT Tensiometer (Krϋss) [32]. 
The surface tension of sterile ZM/1 media supplemented 
with 1% (v/v) rapeseed oil (Sigma-Aldrich) was also 
measured as a comparative control. To evaluate for emul-
sification, the emulsification index (EI) of the supernatant 
fractions was measured by adding 2 mL of the superna-
tant to an equal volume of kerosene and vortexing at high 
speed for 2 min. The stability of resultant emulsions was 
observed after 24 h settlement. The  EI24 (i.e. EI after 24 h) 
was calculated as a percentage of the height of the emul-
sified layer to the total height of the liquid prior to emul-
sification by vortexing [33]. As a control for comparison, 
sterile ZM/1 medium was used.
Optimization of growth conditions
The growth of MCTG107b in different physical and 
media conditions was investigated. For this, shake flask 
Table 1 Phylogenetic identification and biosurfactant phenotypic screening results for each bacterial strain
Bacteria were identified by 16S rDNA gene sequencing. Surface tension values (mN m−1) and  EI24 (%) were obtained from cell-free supernatant samples of cultures 
incubated for 96 h
a ST and bEI 24 h of sterile ZM/1 medium was 58  mNm−1 and 0%, respectively
Strain Origin BLASTn identification 
(against NCBI database)
GeneBank 
accession 
number
Sequence 
similarity 
(%)
Phenotypic screening
ST (mN m−1)a EI24 h (%)
b
MCTG106 Coastal surface water, Oregon, Washing-
ton State, USA
Marinobacter sp. NP1383C-30R MK894600 100 54.63 ± 3.5 40 ± 1.5
MCTG4b Laboratory culture of Thalassiosira weiss-
flogii strain CCMP 1052 isolated from 
Oslo Fjord, Norway
Marinobacter sp. Set72 MK894835 99 38.5 ± 0.6 42 ± 2.0
MCTG167 Phytoplankton net tow, Oban, UK Marinobacter sp. T23 MK894854 100 61.55 ± 0.1 N/A
MCTG161(2c3) Phytoplankton net tow, Oban, UK Marinobacter adhaerens HP15 MK894872 99 60.0 ± 0.5 45 ± 2.0
MCTG107b Coastal surface water, Oregon, Washing-
ton State, USA
Marinobacter sp. R-28768 MK578516 100 31.0 ± 0.5 40 ± 1.8
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experiments were carried out in 1  L Erlenmeyer flasks 
containing 90 mL of ZM/1 medium and inoculated (10% 
v/v) with a seed culture grown under the standard condi-
tions described earlier. For the carbon source, glucose 1% 
(w/v) final concentration was used in all experiments. All 
flasks were incubated in a rotary orbital incubator set at 
200 rpm. However, physical and media conditions tested 
included various concentrations of sea salts (5, 10, 20, 30 
and 40 g L−1), temperature (25, 28, 30 and 37 °C) and pH 
(4.0, 5.5, 7, 8.5). Samples of the culture medium in these 
various experiments were taken at various time points for 
optical density (OD) measurements at 600 nm to monitor 
the growth of the cells.
Optimisation of growth media for biosurfactant 
production
The effect of sea salt concentration and pH for enhance-
ment of biosurfactant production by MCTG107b was 
carried out by FFD, using surface tension, (measured as 
described previously), and biosurfactant yield, (measured 
gravimetrically), as response variables. These experi-
ments were carried in shake flask culture using ZM/1 
medium supplemented with 1% (v/v) rapeseed oil with 
various concentrations of sea salts (5 to 40  g  L−1) and 
pH (5.5 to 8.5) according to the experimental designs 
(Additional file 1: Table S1). In total, 14 experiments were 
performed  (22 FFD with 8 assays and 6 replicates at the 
centre point).
Biosurfactant extraction and purification
Biosurfactant compounds were extracted and purified 
from 3-L cultures of strain MCTG107b when grown in 
optimised ZM/1 medium supplemented with 1% (v/v) 
rapeseed oil using a 5.0 L Biostat B bioreactor (Sarto-
rius Stedim) equipped with a mechanical foam separa-
tor. The reactor vessel was inoculated (10% v/v) with a 
MCTG107b seed culture grown to exponential phase in 
ZM/1 supplemented with 1% (w/v) glucose at 30 °C and 
200 rpm. Internal temperature of the culture was main-
tained at 30  °C throughout the growth cycle. Stirrer 
speed and aeration varied between 300 and 600  rpm in 
order to maintain  DO2 levels at 50%. Cultures were incu-
bated for 96 h; during growth, dissolved oxygen and pH 
were continually monitored and samples were taken at 
24 h intervals to monitor growth and BS.
At the termination of the culture (96  h), the biosur-
factants were extracted using liquid phase extraction. For 
this, the culture volume was first centrifuged (13,000×g; 
15 min) and then the supernatant collected and acidified 
to pH 2.0 with 1 M HCl (Sigma-Aldrich) prior to extrac-
tion three times with an equal volume of ethyl acetate 
(Sigma-Aldrich). The organic phase was separated and 
dried using  MgSO4 (Sigma-Aldrich), filtered and rotary 
evaporated under vacuum at 40  °C to obtain a crude 
extract [34]. Crude extracts were then purified by Solid 
Phase Extraction (SPE) using Strata SI-1 Silica (55  μm, 
70  Å) Giga tubes (Phenomenex). Purified BS extracts 
were gravimetrically assessed and stored at 4 °C for fur-
ther analysis [35].
Chemical analysis of biosurfactant compounds
Biosurfactant compounds extracted from strain 
MCTG107b were initially analysed using the orcinol 
method [34]. To each 100 μL sample, 900  μL of a solu-
tion containing 0.19% (w/v) orcinol (Sigma-Aldrich) in 
53%  H2SO4 (Sigma-Aldrich) was added. Samples were 
then heated to 80 °C for 30 min, after which the samples 
were cooled to room temperature. The absorbance of the 
samples was measured at 421 nm. The concentration of 
glycolipid present in the samples were calculated to those 
generated using a standard rhamnose at concentrations 
of 0–100 μg mL−1 [36].
Individual biosurfactant congeners were identified in 
the SPE purified extract by a UHPLC system with RS 
Diode Array detector (ThermoFisher Scientific) in con-
junction with the amaZon SL dual funnel Ion Trap spec-
trometer LCMS system (Bruker). An analytical column 
of Acclaim RSLC, 120 C18, 2.2 μm 120 Å (2.1 × 100 mm) 
(ThermoFisher Scientific) was used for analysis. The gra-
dient elution sequence used was as follows: 20% B to 
100% in 30 min, 100% B for 10 min, 20% B in 5 min. Sol-
vents A = H2O (0.1% TFA), B = AcCN (0.1%TFA). The 
sample injection volume used was 10 μL. Spectra were 
acquired in the positive mode from m/z 200 to 2000. 
Tandem-MS was performed using Thermos System LC 
P4000 (ThermoFisher Scientific) coupled to a LCQ clas-
sic MATT ion trap mass spectrometer (ThermoFisher 
Scientific) equipped with a 150 × 4.6 mm Kinetex 5 µM 
F5 100 Å LC column. HPLC-grade water and analytical-
grade acetonitrile were used as mobile phase. The sample 
injection volume was 5 µL and the spectra were acquired 
in the negative mode from m/z 175 to 700. The fragmen-
tation of the molecules was done with helium gas at the 
normalised 40% collision energy with the activation q 
value of 0.25.
Galleria mellonella infection model
Virulence assessment of strain MCTG107b was car-
ried out using the G. mellonella infection model [38]. A 
comparative positive control for these experiments was 
P. aeruginosa PAO1 (ATCC 15692). Using the Miles and 
Misra method [37], viable count (CFU) and OD 600 nm 
were correlated throughout the growth cycles of both 
strains. Following this, 10 mL of stationary phase culture 
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was centrifuged (10,000×g; 20  min) and the pelleted 
cells washed in sterile phosphate buffered saline (PBS). 
The washed cells were re-suspended to OD 600  nm 0.4 
in PBS to a concentration of 5 × 104 CFU mL−1. G. mel-
lonella larvae (Pets at Home, Belfast) of approx. 20 mm in 
length and 200 mg in weight were selected and 20 μL of 
either bacterial sample (1000 CFU) or PBS (negative con-
trol) was injected into the posterior pro-leg of individual 
larvae (n = 10 per experimental group). Injection was 
carried out using a 0.30 mm (30G) × 8 mm hypodermic 
needle (BD). Immediately following injection, the larvae 
were incubated at 37 °C and observed at set time points 
during the course of a 48  h period. At each time point, 
individual larva was recorded as either live or dead. The 
experiment was performed on three independent occa-
sions which gives a total of n = 30 per experimental group 
[20, 38].
Statistical analysis and data availability
Statistical analysis of bacterial growth experiments was 
carried out in GraphPad Prism V.7 using a one-way 
ANOVA followed by Tukey’s post hoc testing; the signifi-
cance of the results was tested at p < 0.05 level. The data 
obtained from FFD experiments were subjected to statis-
tical analysis by TIBCO Statistica software version; the 
significance of the results was tested at p < 0.05 level. All 
sequence data was submitted to GenBank (NCBI, USA) 
and the assigned accession numbers of strains are given 
in Table 1.
Results
Strain identification and initial phenotypic screening
Five marine bacterial isolates—MCTG107b, MCTG4b, 
MCTG106, MCTG167 and MCTG161(2c3)—were inves-
tigated for biosurfactant production. BLASTn analysis 
of partial 16S rRNA gene sequences from these strains 
showed > 99% similarity to the genus Marinobacter 
(Table 1). Following phenotypic screening, strains which 
reduced the surface tension of culture medium to below 
35 mN m−1 and/or produced a stable emulsion after 24 h 
were considered as potential biosurfactant(s) producers 
(Table  1). Strain MCTG167 was unable to form a sta-
ble emulsion or to significantly reduce the surface ten-
sion when compared to un-inoculated medium controls 
(58 mN m−1). Strain MCTG106 and MCTG161(2c3) also 
showed no significant reduction in surface tension, how-
ever both strains were able to form stable emulsions after 
24 h. Strain MCTG4b emulsified kerosene with an  EI24 of 
40%, whereas it reduced the ST of supernatant fractions 
to 38.5 mN m−1. Strain MCTG107b showed the highest 
surface activity, significantly reducing the surface tension 
of the culture broth to 31 mN m−1, and producing stable 
emulsions with kerosene  (EI24 of 40%). Therefore, Mar-
inobacter sp. MCTG107b was selected for further study.
Bacterial growth of Marinobacter sp. MCTG107b
To determine optimal conditions for the growth of Mar-
inobacter sp. MCTG107b, and with a view to optimising 
its production of biosurfactant, growth was monitored 
in different physical and media conditions that included 
evaluating different salinities, pH, temperatures and 
nitrogen sources. Marinobacter sp. MCTG107b grew 
optimally at a range of salinity concentrations, from 5.0 
to 40 g L−1 sea salts. In medium containing no added sea 
salts, no growth was observed. Strain MCTG107b grew 
optimally within a pH range of 5.5 to 8.5, whereas it was 
significantly inhibited under more acidic conditions (pH 
4.0). The strain grew optimally at temperatures ranging 
from 25 to 37 °C (Additional file 1: Fig. S1).
Optimization of culture conditions for biosurfactant 
production
To optimise the media composition for maximal biosur-
factant production by strain MCTG107b, the effects of 
salinity and pH, as well as the interaction between these 
variables was assessed by applying FFD,  22. Compared to 
pH, salinity was observed to be the most important fac-
tor affecting the reduction of surface tension when this 
was measured for cell-free culture supernatant fractions. 
The surface tension was found to vary between 30.5 to 
40.2 mN m−1 (Additional file 1: Table S1). Experimental 
results were used to generate two equations that mod-
elled the relation between pH/salinity and the outputs 
biosurfactant yield and surface tension. According to the 
response values obtained from the designed experiments, 
the following regression equations were obtained for 
both biosurfactant yield (1) and surface tension (2):
Significance of the present model was validated 
through analysis of variance (p ≤ 0.05) (Additional file 1: 
Table  S2). The observed values for biosurfactant yield 
were significantly close to those determined by the model 
 (R2 = 0.996). The observed and the predicted values for 
surface tension modelled here also demonstrated that the 
(1)
Yield = 22.17262+ 39.88095 ∗ pH(1)+ 36.60714
∗ Salts(2)− 4.64286 ∗ pH ∗ Salts
(
1 by 2
)
(2)
Surface Tension = 50.03036− 1.70714 ∗ pH(1)
− 0.55690 ∗ Salts(2)+ 0.05476
∗ pH ∗ Salts
(
1 by 2
)
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experimentally observed values were significant to those 
determined by the model  (R2 = 0.958). Results from the 
FFD analysis for the outputs of biosurfactant yield and 
surface tension were expressed as 3D response surface 
plots showing the relationship between independent and 
dependent variables (Fig.  1). Increased salinity signifi-
cantly and positively influenced biosurfactant yield. Our 
model demonstrated a significant relationship between 
biosurfactant yield and the two variables tested (salinity 
and pH). We modelled an increased biosurfactant yield 
when pH was low and salinity was increased from the 
central to the highest level. The increase in salinity posi-
tively influenced biosurfactant yield, in a statistically sig-
nificant way (Fig.  1a). Similarly, the model showed that 
an increase in pH did not cause major impacts on surface 
tension, whereas an increase in salinity from the central 
to highest point led to a decrease in surface tension. The 
results of reduction in superficial tension agree with the 
biosurfactant yield. However, the 3D response surface 
plots of both dependent responses are not a coincident. 
Since, the increase in salinity concentration negatively 
influenced, in a statistically significant way, the increase 
in biosurfactant production, leading to lower surface ten-
sion (Fig.  1b). These data demonstrate salinity and pH 
are critical factors that markedly affected the produc-
tion yield of biosurfactant. Our model showed maximum 
production of biosurfactant at a pH 5.0–6.8 and salinity 
22.5–40.0 g L−1, resulting in a predicted yield of between 
460 and 800 mg L−1. The optimised medium with a sea 
salt concentration of 30  g  L−1 and pH 6.5 was there-
fore chosen for all subsequent experiments with strain 
MCTG107b.
Growth and biosurfactant production by Marinobacter sp. 
MCTG107b in a bioreactor
Based on our results above, an optimised culture medium 
was used to produce biosurfactant from Marinobacter 
sp. MCTG107b employing a bench-scale 5.0 L bioreac-
tor. Biomass, culture pH and surface tension were moni-
tored continually throughout the growth cycle. The cell 
concentration at the time of inoculation (t = 0  h) was 
2.02 × 106 CFU mL−1. An exponential growth phase was 
maintained for the first 24  h, followed by a stationary 
phase from 24 to 96 h, and the cell concentration reach-
ing 6.46 × 109 CFU mL−1 by the end of the fermentation 
(Fig. 2). The pH of the culture was observed to fall dur-
ing the course of the exponential growth phase and then 
remained moderately constant during the stationary 
phase. A similar pattern was observed for the surface ten-
sion that was measured for cell-free supernatant samples 
Fig. 1 Three-dimensional response surface plot modelling the effect of varying media pH and salt concentration on a biosurfactant yield and b 
cell-free supernatant surface tension. The different coloured areas of these plots represent various bands for either predicated yield or predicted 
surface tension. The values of each band are provided in the key next to each panel
Fig. 2 Biomass and surface tension reduction kinetics of 
Marinobacter sp. MCTG107b during growth under optimised 
conditions using 1% (v/v) rapeseed oil as a carbon source in a 5 L 
bioreactor. Surface tension (open square) was seen to reduce to a 
stable value within the first 24 h of growth and corresponded with 
the strain reaching the stationary growth phase, as measured by 
viable cell counts (open circle)
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over the course of the growth phase. The strain achieved 
the lowest surface tension value (31 ± 0.7 mN m−1) after 
24 h of fermentation and then remained almost constant 
until the end of the fermentation (Fig. 2). When assessed 
gravimetrically, the mean biosurfactant yield obtained by 
liquid phase extraction and SPE purification of the cell-
free supernatant volume from replicate 96  h bioreactor 
cultures of Marinobacter sp. MCTG107b was 740 mg L−1 
(± 28.3 mg L−1).
Chemical characterisation of the biosurfactant produced 
by Marinobacter sp. MCTG107b
The traits measured for biosurfactant production (i.e. 
surface tension reduction and emulsification) were 
indicative that Marinobacter sp. MCTG107b produces a 
glycolipid biosurfactant. To confirm this, Orcinol assays 
followed by HPLC–MS analysis were carried out on 
samples obtained from the bioreactor cultures. Orcinol 
assays performed with cell-free supernatant samples 
indicated the presence of glycolipids at 150  µg  mL−1 
of culture. The production and presence of glycolipids 
was further investigated by mass spectrometric analy-
sis. The identification of glycolipid congeners produced 
by strain MCTG107b was characterized by HPLC–MS 
operating in the positive mode. The observed products 
possessed m/z values that corresponded to values for 
known rhamnolipids, indicating that the biosurfactant 
synthesised by strain MCTG107b was a mixture of 
rhamnolipid congeners. We identified a variety of sepa-
rate rhamnolipid congeners present in purified cell-free 
supernatant extracts from culture samples of the strain 
(Table  2). These congeners included both mono- and 
di-rhamnolipids; however, there was an overwhelm-
ing preference toward the synthesis of di-rhamnolipid 
(95.39% of total rhamnolipid abundance). The conge-
ner with the highest relative abundance (52.45%) pos-
sessed an m/z value of 651.73. This value correlated 
with α-l-rhamnopyranosyl-α-l-rhamnopyranosyl-
β-hydroxydecanoyl-β-hydroxydecanoate (Rha-Rha-
C10-C10) with a molecular weight of 650.79  Da. The 
next most abundantly synthesised congeners were 
Rha-Rha-C10-C10CH3 (23.07%), Rha-Rha-C10 (5.13%), 
Rha-Rha-C10-C12 (5.01%), Rha-Rha-C10-C12CH3 (3.26%) 
and Rha-C14:2 (3.18%) (Table  2). As rhamnolipid pro-
duction has not been previously observed in any mem-
ber of the Marinobacter genus, these data were further 
investigated for confirmatory evidence of this. For 
this, tandem-MS was performed on the major molecu-
lar ion shown to be synthesised by strain MCTG107b. 
Tandem-MS analysis of the compound with an m/z of 
651.73 revealed the detection of ‘daughter’ ions with 
molecular weights indicative of the fragmentation of 
Rha-Rha-C10-C10 (Fig. 3). These data, together with the 
phenotypic results and initial HPLC–MS and Nuclear 
Magnetic Resonance (NMR) spectroscopy analysis 
Table 2 Composition of rhamnolipid congeners synthesised by Marinobacter sp. MCTG107b
Rhamnolipid congeners were identified via HPLC–MS in SPE purified extracts from cell-free culture supernatant samples obtained after 96 h growth in a bioreactor
RT min m/z value Compound Mw (Da) Molecular form Relative %
Mono-rhamnolipid congeners
 14.8 387.22 Rha-C14:2 386.48 C20H34O7 3.18
 21.5 533.46 Rha-C10-C12/Rha-C12-C10 532.71 C28H52O9 0.22
 24.2 503.47 Rha-C10-C10:1 502.64 C26H46O9 0.27
 26.9 561.52 Rha-C12-C12/Rha-C10-C14 560.76 C30H56O9 0.94
 Subtotal 4.61
Di-rhamnolipid congeners
 4.6 453.27 Rha-Rha-C8 452.49 C20H36O11 1.95
 12.7 480.39 Rha-Rha-C10 480.55 C22H40O11 5.13
 22.1 537.45 Rha-Rha-C14 536.65 C26H48O11 0.21
 31.0 649.71 Rha-Rha-C10-C10:1/Rha-Rha-C10:1-C10 648.74 C32H56O13 2.85
 32.1 651.73 Rha-Rha-C10-C10 650.79 C34H58O13 52.45
 32.8 677.77 Rha-Rha-C10-C12:1 676.83 C33H60O13 1.06
 33.0 665.77 Rha-Rha-C10-C10-CH3 664.82 C42H60O13 23.07
 34.5 803.54 Decenoyl-Rha-Rha-C10-C10:1 801.01 C35H72O11 0.40
 35.1 679.78 Rha-Rha-C10-C12/Rha-Rha-C12-C10 678.84 C35H64O13 5.01
 37.2 693.90 Rha-Rha-C10-C12-CH3/Rha-Rha-C12-C10-CH3 692.80 C35H64O13 3.26
 Subtotal 95.39
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(data not shown), confirms the synthesis of rham-
nolipid by Marinobacter sp. MCTG107b.
Assessment of virulence using the Galleria mellonella 
infection model
The potential virulence of Marinobacter sp. MCTG107b 
was assessed and compared to that of the rhamnolipid 
producing opportunistic pathogen P. aeruginosa using 
the G. mellonella infection model. P. aeruginosa PAO1 
killed 100% of the infected larvae 24  h post inoculation 
with as little as 1000  CFU. When larvae were inocu-
lated with an equal CFU count of Marinobacter sp. 
MCTG107b or with sterile PBS, the larvae showed 97% 
survival 48 h post inoculation, with only one larva dying 
in each experimental group at 22 and 20 h post inocula-
tion respectively (Fig. 4). Similar survival rates were also 
observed when larvae were inoculated with significantly 
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Fig. 3 HPLC–MS–MS profile of daughter products resulting from the fragmentation of a molecular ion with an m/z of 651.73, observed in a 
previous HPLC–MS analysis to be the predominant compound in supernatant extracts from Marinobacter sp. MCTG107b. The observed products 
corresponded to the predicted molecular weights of the fragmentation of di-rhamnolipid Rha-Rha-C10-C10. Fragments below m/z 205 were not 
detected due to sensitivity of the instrument
Fig. 4 Kaplan–Meier plot showing percentage survival of Galleria 
mellonella larvae after inoculation with either Marinobacter sp. 
MCTG107b or P. aeruginosa PAO1. Within a 48 h incubation there was 
no significant mortality observed after infection with cells of strain 
MCTG107b as opposed to infection with strain PAO1 where 100% 
mortality was observed following 24 h incubation. Additionally, 
no significant mortality was observed in larvae inoculated with 
the carrier control buffer (PBS). n = 30 (pooled from 3 × duplicate 
experiments)
Page 9 of 12Tripathi et al. Microb Cell Fact          (2019) 18:164 
higher doses of Marinobacter sp. MCTG107b (up to 
10,000 CFU in 20 µL) (data not shown).
Discussion
Marine bacteria are reported to secrete surface-active 
molecules that can interact with hydrocarbons to 
increase the emulsification of the hydrocarbon molecules 
in seawater to enable these, and also non-biosurfactant 
producing bacteria to access these molecules for uptake 
and use as a source of carbon and energy [39, 40]. Marin-
obacter, a genus of Gammaproteobacteria, has previously 
been shown capable of utilising hydrocarbons as growth 
substrates by producing biosurfactants or bioemulsifier 
[41, 42]. In the present study, five marine bacterial strains, 
which were originally isolated for their ability to grow 
on and degrade PAHs, were identified to belong to the 
genus Marinobacter based on 16S rDNA gene sequenc-
ing. These isolates were screened to evaluate their poten-
tial as biosurfactant producers when cultivated in marine 
media using rapeseed oil as a carbon source. Many previ-
ous studies have reported that the inclusion of peptone in 
marine media is essential for biosurfactant synthesis [43, 
44]. Here we show that in response to adding rapeseed 
oil to peptone containing ZM/1 media, these five Mar-
inobacter strains displayed varying phenotypic responses 
which were indicative of biosurfactant synthesis. Pheno-
typic comparison of all these strains showed that Marin-
obacter sp. MCTG107b, isolated from sea surface water 
samples off the coast of Oregon, USA, showed maximum 
reduction in the surface tension of cell-free supernatant 
fractions. As the ability to reduce the surface tension of 
cell-free supernatant is a key phenotypic marker of low-
molecular weight biosurfactant synthesis, this strain was 
selected for further investigation [45].
Considering that subtle changes in salinity and pH 
can exert an important effect on microbial communi-
ties in the marine environment [46, 47], these param-
eters were tested for their influence on the growth of 
strain MCTG107b and its production of biosurfactant. 
Indeed, several studies have shown the effect of these 
two parameters on bacterial biosurfactant synthesis. For 
example, Bacillus subtilis N3-1P, isolated from brewery 
waste, reduced the surface tension of the culture medium 
to the greatest extent at a pH of 6.41 when compared 
to a range of other media pHs [48]. A thermophilic and 
halo-tolerant strain of P. aeruginosa, isolated from oil-
contaminated soil, produced biosurfactant when cul-
tured in media containing a salinity range of 0–6% (w/v) 
[49]. In contrast Bacillus licheniformis BAS50, isolated 
from a deep oil well, produced biosurfactant when using 
a salinity of up to 13% NaCl, which is a salinity equiva-
lent to that present in many petroleum reservoirs [50]. 
Based on these previous studies, we carried out FFD 
modelling to identify optimal concentrations of salinity 
and pH for the maximal production of biosurfactant by 
strain MCTG107b, and which revealed that a pH range 
of 5.0–6.8 and salinity concentration of 22.5–40  g  L−1 
were optimal. Interestingly, while salinity was the domi-
nant factor affecting the reduction of surface tension, 
the strain preferred an acidic pH for increased biosur-
factant production. This was at the expense of bacterial 
growth, indicating that when the culture medium was 
alkaline, cells were directed to the production of cellular 
biomass over biosurfactant synthesis. Whilst not within 
the focus of this study, future work could be directed to 
explore this pH-mediated biosurfactant response and 
whether it is transposable to the global ocean in order to 
predict microbial biosurfactant production under future 
climate change conditions, such as ocean acidification. 
The profile of a marked fall in surface tension during the 
exponential growth phase coupled with a sustained low 
surface tension during stationary phase indicated the 
biosurfactant produced by strain MCTG107b is likely a 
secondary metabolite, as has been similarly reported for 
P. aeruginosa [51], B. thailandensis [23] and marine Pseu-
domonas sp. MCTG214(3b1) [20].
Orcinol assay yielded 150  μg  mL−1 of rhamnolipid in 
the cell free supernatant. Orcinol assay is a colorimetric 
method for the rapid indication of rhamnolipid in the 
fermentation broth. However, the limitation of orcinol 
method is that, it is not specific for rhamnose and impu-
rities present in the sample might interfere with the 
actual yield. We followed the criteria suggested by Irorere 
et al. [35] to quantify biosurfactant yield gravimetrically. 
The final yield of rhamnolipid was 740 ± 28.3  mg  L−1 
from the SPE purified sample. SPE purification of crude 
biosurfactant removed excess lipids from the sample 
which gave an absolute quantification of rhamnolipid 
yield. Similarly, Perfumo et  al. [51] reported purified 
rhamnolipid yields in the range of 0.8–1.7 g L−1 from P. 
aeruginosa strains. While, the orcinol assay provided an 
overestimation of rhamnolipids at 7.7–9.5 g L−1.
The chemical characterisation of the purified biosur-
factant synthesised by strain MCTG107b was achieved 
using HPLC–MS—a methodology demonstrated to be 
the most effective for identifying biosurfactant com-
pounds [35]. We identified 14 separate rhamnolipid 
congeners with Rha-Rha-C10-C10 (m/z 651) being the 
most abundant (52.45%). Furthermore, elucidation of 
this major molecular ion synthesised by Marinobacter 
sp. MCTG107b was performed by tandem-MS. When 
fragmented by MS–MS, the parent ion showed charac-
teristic fragments at m/z 479 and m/z 339, which were in 
agreement with the previous tandem-MS analysis of Rha-
Rha-C10-C10 performed by Zhao et  al. [52]. The pattern 
of rhamnolipid congeners synthesised by this strain was 
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highly similar to the rhamnolipid congeners that have 
been shown to be produced by both P. aeruginosa and 
marine Pseudomonas sp. MCTG214(3b1), but contrasts 
with B. thailandensis which produces an abundance of 
congeners with di-rhamnolipid containing  C14 [18, 20, 
23]. The composition of rhamnolipid congeners greatly 
affects its properties. Mono-rhamnolipids have been 
reported to more effectively solubilise PAHs compared 
to di-rhamnolipids. However, di-rhamnolipids have bet-
ter rate of biodegradation than mono-rhamnolipids due 
to the slow release of PAH from the mono-rhamnolipid 
micelles [53]. This was seen with methyl esters of di-
rhamnolipid which were reported to be effective in pro-
moting alkane degradation [54]. Interestingly, non-ionic 
rhamnolipids or methyl esters of di-rhamnolipid  C10-C10 
and novel methyl ester of di-rhamnolipid  C10-C12 were 
also identified in this study. In this study a mono-rham-
nolipid with single 3-hydroxy fatty acid chain Rha-C14:2 
(3.18%) was also detected which was previously reported 
in rhamnolipid produced by P. aeruginosa mutant 
MIG-N146 [55]. Under our experimental conditions, 
MCTG107b was able to produce diverse rhamnolipid 
congeners with aliphatic chains varying from  C8 to  C14 
and few congeners with unsaturated bonds.
The biosynthesis of rhamnolipids in P. aeruginosa 
occurs in three enzymatic steps. In the first step, rham-
nosyltransferase chain A RhlA (encoded by the rhlA 
gene), synthesizes a fatty acid dimer molecule from 
β-hydroxy fatty acid precursors [56]. The second step, 
RhlB rhamnosyltransferase chain B (encoded by the 
rhlB gene), produces mono-rhamnolipids by covalently 
bonding the previously synthesised precursor mol-
ecule and dTDP-l-rhamnose [57]. The final step, RhlC 
rhamnosyltransferase II (encoded by rhlC gene), utilises 
mono-rhamnolipids synthesised by RhlA and RhlB as a 
substrate, adding a second dTDP-l-rhamnose moiety to 
produce di-rhamnolipids [58]. The rhamnolipid conge-
ner profile produced by Marinobacter sp. MCTG107b is 
predominantly skewed toward the synthesis of di-rham-
nolipids, whereas mono-rhamnolipids were only found 
in much smaller concentrations. Although a prevalence 
toward di-rhamnolipid synthesis has been observed in P. 
aeruginosa, and to an even greater extent in Burkholde-
ria species, the abundance of di-rhamnolipid versus 
mono-rhamnolipid in Marinobacter sp. MCTG107b was 
significantly higher than that previously observed with 
other rhamnolipid-producing organisms. In P. aeruginosa 
a single copy of rhlA and rhlB are located in an operon 
alongside genes encoding an AHL-mediate quorum sens-
ing system. The rhlC gene is located approx. 1 Mbp down 
stream of this operon [51]. A contrasting arrangement 
was observed in B. thailandensis which has two identi-
cal and functional operons containing orthologues of 
each rhamnolipid synthesis gene (rhlA, rhlB and rhlC), 
possessing only 40% sequence similarity to those of P. 
aeruginosa [23, 59]. Therefore, Burkholderia species 
can simultaneously express rhlB and rhlC favouring the 
immediate addition of the second rhamnosyl group to 
the produced mono-rhamnolipid [59].
We therefore postulate that a biosynthetic path-
way similar to that observed in Burkholderia might 
be present here and accounting for the higher ratio of 
di-rhamnolipid to mono-rhamnolipid congeners. The 
biosynthetic pathway of rhamnolipid synthesis by Mar-
inobacter sp. has however presented a paradox. Although 
not shown here, we have carried out additional PCR 
screening for rhlA, rhlB and rhlC using degenerate prim-
ers designed from multiple sequence alignments of both 
P. aeruginosa and B. thailandensis sequences. To date, 
this approach has failed to amplify any DNA sequence 
which could be involved in rhamnolipid synthesis gene 
orthologues. Our finding that other similar Marinobacter 
strains fail to synthesise rhamnolipids suggests that the 
acquisition of rhamnolipid biosynthesis genes by Mar-
inobacter sp. MCTG107b may have occurred through 
lateral gene transfer from an unrelated rhamnolipid pro-
ducing species, as has been observed previously in other 
rhamnolipid synthesising bacteria [60]. However, based 
on the un-relatedness of Marinobacter sp. MCTG107b 
to previously reported rhamnolipid producers and the 
significant sequence differences between the P. aerugi-
nosa and B. thailandensis synthases, we conclude that 
rhamnolipid synthesis in this strain is being catalysed by 
enzymes with significantly different peptide sequences to 
either of these other species. This sequence difference is 
also present at the genetic level, accounting for the rea-
sons why our screening protocol failed [23, 59]. Addi-
tionally, the observation of mono-rhamnolipid congeners 
only possessing a single fatty acid side chain being syn-
thesised by this strain corroborates this conclusion since 
RhlA in both P. aeruginosa and Burkholderia species uti-
lises fatty acid dimers as a substrate for rhamnolipid syn-
thesis [56, 59]. To further investigate the mechanisms of 
rhamnolipid biosynthesis, we recently obtained the com-
plete genome sequence of Marinobacter sp. MCTG107b. 
We are therefore, currently in the process of carrying out 
comparative genomic analysis with various other Mar-
inobacter strains, with the aim of identifying putative 
genetic candidates for rhamnolipid biosynthesis.
Conclusions
Marinobacter sp. MCTG107b, isolated from the marine 
environment, has the ability to synthesise a wide vari-
ety of rhamnolipid congeners. To the best of our knowl-
edge, rhamnolipid production has not been previously 
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observed in any member of the genus Marinobac-
ter. Therefore, the results presented here expand the 
list of known rhamnolipid producing bacterial taxa 
to include Marinobacter; a genus of marine bacteria 
that shows little to no association with human patho-
genicity. Although the major hurdle of low production 
yield remains, synthesis of rhamnolipids from novel, 
non-pathogenic marine species, such as Marinobacter 
sp. MCTG107b, is promising for the scale-up in bio-
processing industry or to provide genetic resources for 
metabolic engineering for the production of specific 
rhamnolipid congeners.
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